Position in NVS
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$11,126
+$282 QoQ
Shares Held
71
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,534
of 1,603 holders
Holding Since
Dec 2023
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Caitlin John, LLC holds $1,198,679 across 12 Drug Manufacturers - General names. NVS ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
19,323 | $465,297 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
3,822 | $220,222 | |
| 3 | JNJ |
Johnson & Johnson
|
539 | $136,888 | |
| 4 | MRK |
Merck & Co., Inc.
|
876 | $112,566 | |
| 5 | AMGN |
Amgen Inc
|
255 | $92,340 | |
| 6 | LLY |
ELI LILLY & Co
|
53 | $63,569 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
351 | $44,345 | |
| 8 | ABBV |
AbbVie Inc.
|
149 | $37,494 |
All Filings in NVS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,126 | 71 | Shares | Sole | 2026-08-17 | |
| 2026-03-31 | $10,844 | 71 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $8,546 | 62 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $7,949 | 62 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $5,254 | 54 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $6,211 | 54 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $5,748 | 54 | Shares | Sole | 2025-01-27 | |
| 2024-03-31 | $11,607 | 120 | Shares | Sole | 2025-01-27 | |
| 2023-12-31 | $12,419 | 123 | Shares | Sole | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||